{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:45:43Z","timestamp":1776732343233,"version":"3.51.2"},"reference-count":60,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["CPT Pharmacom &amp; Syst Pharma"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Therapeutic drug monitoring (TDM) of busulfan (BU) is currently performed by plasma sampling in patients undergoing hematopoietic stem cell transplantation (HSCT). Saliva samples are considered a noninvasive TDM matrix. Currently, no salivary population pharmacokinetics (PopPKs) model for BU available. This study aimed to develop a PopPK model that can describe the relationship between plasma and saliva kinetics in patients receiving intravenous BU. The performance of the model in predicting the area under the concentration\u2010time curve at steady state (AUC<jats:sub>ss<\/jats:sub>) based on saliva samples is evaluated. Sixty\u2010six patients with HSCT were recruited and administered 0.8\u2009mg\/kg BU intravenously. A PopPK model for saliva and plasma was developed using the nonlinear mixed effects model. Bayesian maximum a posteriori (MAP) optimization was used to estimate the model's predictive performance. Plasma and saliva PKs were adequately described with a one\u2010compartment model and a scaled central compartment. Body surface area correlated positively with both clearance and apparent volume of distribution (Vd), whereas alkaline phosphatase correlated negatively with Vd. Simulations demonstrated that the percentage root mean squared prediction error and lower and upper limits of agreements reduced to 10.02% and \u221216.96% to 22.86% based on five saliva samples. Saliva can be used as an alternative matrix to plasma\u00a0in TDM of BU. The AUC<jats:sub>ss<\/jats:sub>can be predicted from saliva concentration by Bayesian MAP optimization, which can be used to design personalized dosing for BU.<\/jats:p>","DOI":"10.1002\/psp4.13004","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T05:15:56Z","timestamp":1690348556000},"page":"1238-1249","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Saliva as a noninvasive sampling matrix for therapeutic drug monitoring of intravenous busulfan in Chinese patients undergoing hematopoietic stem cell transplantation: A prospective population pharmacokinetic and simulation study"],"prefix":"10.1002","volume":"12","author":[{"given":"Baohua","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Pharmacy Fujian Medical University Union Hospital Fuzhou Fujian China"},{"name":"School of Pharmacy Fujian Medical University Fuzhou Fujian China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Hematology Fujian Medical University Union Hospital Fuzhou Fujian China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4405-0440","authenticated-orcid":false,"given":"Jianxing","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Fujian Medical University Union Hospital Fuzhou Fujian China"},{"name":"School of Pharmacy Fujian Medical University Fuzhou Fujian China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Fujian Medical University Union Hospital Fuzhou Fujian China"},{"name":"School of Pharmacy Fujian Medical University Fuzhou Fujian China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingting","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Pharmacy University of Michigan Ann Arbor Michigan USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4100-5735","authenticated-orcid":false,"given":"Qingxia","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Fujian Medical University Union Hospital Fuzhou Fujian China"},{"name":"School of Pharmacy Fujian Medical University Fuzhou Fujian China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Fujian Medical University Union Hospital Fuzhou Fujian China"},{"name":"School of Pharmacy Fujian Medical University Fuzhou Fujian China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maobai","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Fujian Medical University Union Hospital Fuzhou Fujian China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1640-7385","authenticated-orcid":false,"given":"Xuemei","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Fujian Medical University Union Hospital Fuzhou Fujian China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,7,25]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1188\/06.ONF.E36-E43"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2018.1493734"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2014.04.005"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-514448"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-004-0982-4"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00694339"},{"key":"e_1_2_11_8_1","first-page":"2363","article-title":"Pharmacologically\u2010guided dose adjustment of busulfan in high\u2010dose chemotherapy regimens: rationale and pitfalls (review)","volume":"14","author":"Vassal G","year":"1994","journal-title":"Anticancer Res"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1083-8791(00)70064-4"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24734"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199733050-00001"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1983.134"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.07.013"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704446"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.8.3055"},{"key":"e_1_2_11_16_1","first-page":"225","article-title":"Association of busulfan area under the curve with veno\u2010occlusive disease following BMT","volume":"17","author":"Dix SP","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2011.04.003"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1542\/neo.9-11-e520"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1373\/49.10.1688"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13553"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200645030-00006"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.15.98"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.4196\/kjpp.2012.16.4.273"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-019-04001-2"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-005-0029-0"},{"key":"e_1_2_11_26_1","first-page":"243","article-title":"Determination of busulfan plasma drug concentration by HPLC\u2010MS\/MS","volume":"26","author":"Xie HZB","year":"2014","journal-title":"Strait Pharmaceut J"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31824c2f60"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1445"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-011-9255-z"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000904"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.4196\/kjpp.2012.16.2.97"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15152"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2017.09.050"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2015.015"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012299115260"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2017.142"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000757"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161208785061382"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1993.tb18347.x"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.136.11.1476"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002280000179"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1975173310"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200010000-00003"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.27.5.409"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705252"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703229"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270006295789"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.12735"},{"key":"e_1_2_11_49_1","first-page":"1466","article-title":"Up\u2010regulation of glutathione S\u2010transferase activity in enterocytes of young children","volume":"27","author":"Gibbs JP","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_11_50_1","first-page":"1015","article-title":"Busulfan conjugation by glutathione S\u2010transferases alpha, mu, and pi","volume":"24","author":"Czerwinski M","year":"1996","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02110255"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1960"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.28.1805"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-014-2571-0"},{"key":"e_1_2_11_55_1","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/jcph.130","article-title":"Influence of fludarabine on the pharmacokinetics of oral busulfan during pretransplant conditioning for hematopoietic stem cell transplantation","volume":"53","author":"Castro FA","year":"2013","journal-title":"J Clin Pharmacol"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2011.06.013"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.06.017"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-02-0414"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000442"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-003-0631-y"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01113502"}],"container-title":["CPT: Pharmacometrics &amp; Systems Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/psp4.13004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,17]],"date-time":"2023-12-17T19:33:22Z","timestamp":1702841602000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/psp4.13004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,25]]},"references-count":60,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1002\/psp4.13004"],"URL":"https:\/\/doi.org\/10.1002\/psp4.13004","archive":["Portico"],"relation":{},"ISSN":["2163-8306","2163-8306"],"issn-type":[{"value":"2163-8306","type":"print"},{"value":"2163-8306","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,25]]},"assertion":[{"value":"2023-02-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}